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ABSTRACT 
 
Specific problem: Our previous study showed that the nanofibrous poly-l-lactic acid 
(NF-PLLA) microspheres are excellent cell carriers for tissue regeneration.  However, these 
injectable microspheres are not fluorescent biomaterials. Incorporation of fluorescent 
chromophore into NF-PLLA microspheres will allow imaging for proper delivery of scaffold at 
the specified site and monitor time related degradation in the scaffold, and tissue regeneration by 
live fluorescent imaging, without the need of sacrificing the animals or undertaking elaborate 
histological procedures.  To date, there is no report on the synthesis of fluorescent PLLA. In this 
research, we aim to develop an injectable fluorescent PLLA scaffold for tissue regeneration by 
using Eosin Y (EY) fluorophore as initiator.  
Method: The fluorescent polymer (PLLA-EY) was synthesized by ring-opening 
polymerization (ROP) of l-lactide by bulk polymerization method using stannous octoate 
Sn(Oct)2 catalyst and EY fluorophore initiator, at four different monomer/initiator (M/I) molar 
ratios (20:1,100:1,200:1,400:1). The PLLA-EY polymer was characterized by FT-IR, UV-visible 
spectrophotometry and molecular weight (MW). The smooth walled (SW) and nanofibrous (NF) 
microspheres were fabricated from PLLA-EY 200:1 and 400:1 from methods previously 
described. These were characterized by SEM, confocal, in vitro biodegradation in PBS (pH 
change and SEM) and cytotoxicity testing (MTS assay) on dental pulp stem cells (DPSCs). 
Results: EY initiator generated free radicals causing ROP of l-lactide and incorporation 
of EY in the PLLA polymer chain. FT-IR and UV-vis spectra confirmed incorporation of EY in 
the polymer. Increasing the M/I ratio increased MW of PLLA-EY polymer. Microspheres 
formed from PLLA-EY were auto-fluorescent and increasing the polymer MW resulted in more 
well-defined nanofibers.  Both short term (7d) and long term (21d) cytotoxicity results confirmed 
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non-toxicity of the fluorescent polymer to DPSCs. NF microspheres formed small aggregates 
with cellular extensions between the DPSCs. Biodegradation of NF microspheres was not seen 
until 6 weeks in PBS solution under SEM. 
Conclusion: Fluorescent PLLA-EY polymer and its microparticles can be manufactured, 
and appear to be very promising candidates for dental pulp regeneration. Future studies should 
evaluate the ability to track the polymer and their microparticles in vivo, and their ability to 
accommodate cell adhesion, proliferation, differentiation and in vivo implantation.  
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1. INTRODUCTION 
 
Fluorescence is the property of some atoms and molecules to absorb light at a particular 
wavelength and subsequently emit longer wavelength after a brief interval (1). The fluorescence 
imaging technique uses high intensity light to excite fluorescent molecules in the sample. A 
range of fluorescent materials are available and include organic dyes, genetically encoded 
fluorescent proteins, nanoparticles like carbon and silicon and quantum dots, and fluorescent 
polymeric materials. The high sensitivity, high resolution and safety of fluorescence imaging has 
led to an increasing use of fluorescent biomaterials, specifically fluorescent polymers as bio-
molecular probes in molecular and cell biology as well as implant materials in tissue 
engineering. 
Tissue engineering is “an interdisciplinary field that applies the principles of engineering 
and life sciences toward the development of biological substitutes that restore, maintain, or 
improve tissue function or a whole organ”(2). The advent of tissue engineering and regenerative 
medicine has revolutionized the treatment of impaired organs and missing organs and tissues due 
to disease, trauma, or tumors.  
Biomaterials are critical components in a variety of biomedical applications including 
tissue engineering, drug delivery, and medical devices, the most common ones are the 
biodegradable polymers - polyesters, polyanhydride, polyurethane, polyphosphazenes etc. Of 
these polymers, the biodegradable polyesters such as polylactides, polyglycolides, and their 
copolymers, that are approved by the food and drug administration (FDA) for use in medical 
devices, are of significant interest for biological research. These polymers most commonly 
degrade by a hydrolysis process, in which the ester bond of the polymer breaks down in presence 
of water, although some polymers may also degrade by enzymatic degradation. 
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One of the disadvantages of using biodegradable polymers is that it is very difficult to 
locate these biomaterials both during and after placement in the body. Also, evaluation of time-
related biomaterial degradation is not possible without elaborate invasive procedures like tissue 
dissection and immunohistochemistry. Imparting fluorescence to the polymer biomaterial will 
allow for in vivo imaging for placement and analysis of biodegradation as well tissue 
regeneration by live fluorescent imaging, without the need of sacrificing the animals or 
undertaking elaborate histological procedures. 
This study aimed on imparting fluorescence to the biodegradable polymer poly-l-lactic 
acid (PLLA).  The second section of this thesis is a review of the currently available fluorescent 
biomaterials, with an emphasis on the polymeric biomaterials. This section also reviews the 
injectable scaffolds including details of their types, advantages, disadvantages and use of these 
scaffolds in dental and craniofacial tissue engineering. The goals and aims of the research study 
are also included in this section. The third section includes the research related to synthesis of 
poly-l-lactic acid (PLLA) based fluorescent polymer and its characterization. The fourth section 
contains details about the synthesis of the fluorescent microspheres that were fabricated from the 
fluorescent polymer as well as their characterization and properties. 
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2. LITERATURE REVIEW ON FLUORESCENT BIOMATERIALS 
AND INJECTABLE SCAFFOLDS 
 
2.1 FLUORESCENT BIOMATERIALS 
Fluorescence is a luminescence phenomenon that occurs in fluorescent materials with 
fluorophores. In this process, a fluorophore absorbs light of a particular wavelength and then re-
emits a quantum of light with an energy corresponding to the energy difference between the 
excited state and the ground state (3). Fluorescent biomaterials or fluorophores have gained great 
scientific attention in last few years due to their engrossing properties and important applications 
in the fields of materials and life sciences. Imaging techniques using this property of 
fluorescence are highly reliable and sensitive for detecting an interplay of bio-molecules  with 
each other and with other ionic and molecular species (4).   
The most widely used fluorophores for biomedical applications are both organic and 
inorganic types and these include: 
Organic fluorophores like- 
 Organic Dyes 
 Intrinsic (biological) proteins 
 Fluorescent polymeric materials 
Some of the common inorganic fluorophores are: 
 Metal ligand complexes (Lanthanides chelates) 
 Carbon and silicon nanoparticles 
 Quantum dots 
The above mentioned fluorophores are discussed briefly in the section below. 
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2.1.1 Organic dyes 
Synthetic organic dyes like fluoresceins, rhodamine and cyanines and the newer ones 
like Alexa dyes are the traditional and most established fluorescent labels (5, 6). Fluorescein was 
the first one to be used in biological research . Derivatives of this dye and their bio-conjugates 
like fluorescein isothiocyanate (FITC), rhodamine, tetramethyl rhodamine isothiocyanate 
(TRITC) have also been developed for improved performance. Because of their relatively small 
size, the dye can easily be cross-linked to larger biomolecules like antibodies without interfering 
with their biological function (4). Since these dyes can absorb and emit wavelengths of a wide 
range, they can also be used for multi-colored imaging (7). Applications of the organic dyes 
include as labels for biomolecules, cellular stains and as enzyme-substrates (8). 
These dyes have poor photo-chemical stability and undergo rapid photo-bleaching on 
repeated exposure (7). Also, they possess a wide excitation and emission spectra (short stroke 
shift) and are associated with problems like higher background signal and greater noise to signal 
ratio. There in vivo applications are also largely limited due to associated cell toxicity  (4).  
2.1.2 Intrinsic (biological) proteins 
These proteins are derived from biological sources as the name suggests. Green 
fluorescent protein (GFP), cloned from Aequorea victoria jellyfish, was the first biological 
fluorescent protein to be used for research applications (9, 10). GFP is a well-established marker 
for studying gene expression and protein targeting in cells and organisms (11, 12).  
GFP has also been engineered to produce a vast array of mutants that are broadly 
referred to as genetically engineered fluorescent proteins (FPs) (13). Fluorescent proteins 
undergo photo-bleaching and have a low quantum yield (14, 15).  
Another class of biological proteins is the phycobiliproteins which are stable and highly 
soluble proteins derived from cyanobacteria and eukaryotic algae (16-18). These include 
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fluorophores like allophycocyanin, phycocyanin, and phycoerythrins (19, 20). The broad 
excitation spectra of phycobiliproteins allows for simultaneous detection of more than one 
subpopulation of cells or intracellular organelles by a single excitation source. However, these 
dyes are relatively large sized, which may limit their diffusion into the cells and tissues. These 
are commonly used for biomedical research as fluorescent probes in immunoassays, flow 
cytometry and fluorescent microscopy (18). 
2.1.3 Metal ligand complexes like lanthanide chelates 
Lanthanide chelates are composed of an organic chromophore which is chelated to a 
lanthanide molecule, most commonly terbium (Tb3+) or europium (Eu3+) (21). The chromophore 
is a light sensitive ‘antenna’ and absorbs photons from the excitation light, which is then 
transferred to the lanthanide molecule (22). Lanthanide chelates have a millisecond lifetime and 
long decay times which results in reduced noise to signal ratio and higher detection sensitivity  
(21, 22). This also allows them to be useful in time resolved fluoroscopy measurements (21). 
The chelate can also serve as a scaffold for attaching a reactive group for coupling the 
biomolecules to the fluorophore (22, 23). 
2.1.4 Carbon and silicon nanoparticles 
Fluorescent carbon nanoparticles (FCN) composed of non-toxic carbon are promising 
alternatives to quantum dots for in vivo cell imaging applications where use of QDs is limited 
due to presence of toxic heavy metals (24). Highly fluorescent carbon nanoparticles with tunable 
visible emission have been synthesised recently for biological labeling (25).  
Fluorescent silica nanoparticles (FSNPs) consist of a shell of silica NPs loaded with a 
core of fluorescent dye molecules (26, 27). The fluorescent molecules are somewhat protected 
by the surrounding silica layer, and result in good photostability and brightness (26). The surface 
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of FSNPs can be conjugated to specific biomolecules like drugs, antibodies etc. for drug delivery 
and bioimaging, respectively (28). 
2.1.5 Quantum dots (QDs) 
QDs are fluorescent semiconductor nanocrystals of approximate size range of 1-10 nm, 
which are produced from periodic groups II/VI or III/V. These nanocrystals possess a unique 
highly controlled and well defined spectral property because the absorption and emission 
wavelengths are dependent on the composition and size of the nanocrystals. Smaller particles 
emit shorter wavelengths and larger particles emit longer wavelengths.  
In comparison to organic dyes, QDs have a continuous absorbance spectra and a sharp, 
well defined emission peak. Thus multicolored QDs can be excited by the same light source and 
signal overlap is also not a problem as with organic dyes (29, 30). These also possess higher 
fluorescence intensity and excellent photostability in comparison to organic dyes (29-31).  
The most prominent QD materials for biological applications are CdSe and CdTe (4, 
14).Their surface can be easily conjugated bio-molecular affinity ligands like antibodies, 
peptides as well as therapeutic drugs etc. Current biological applications include cell labeling for 
cellular imaging and tracking and tissue imaging for diagnostic purposes as well as agents for 
delivery of drugs (14, 32-34). However, the presence of heavy metals, such as cadmium and 
selenium for in vivo applications are associated with cytotoxicity and altered cell function (35, 
36). Surface passivation strategies by elaborate biopolymer surface coatings have improved the 
biocompatibility of QDs (37-39) but their long term in vivo effects largely remain unknown. 
2.1.6 Fluorescent polymeric materials 
These are organic polymers which are gaining huge interest in field of biology and 
medicine. There are two ways in which a fluorescent polymer can be synthesized- the traditional 
method is the synthesis of a polymer backbone and conjugating the end with a fluorescent 
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organic dye or QDs (40, 41). Particles made with these polymeric materials offer several 
advantages in bio-applications over their inorganic QDs like diverse functionality (29, 30), 
surface modification, and a higher biocompatibility (42). In particular, photoluminscent 
polymers are being used for a variety of biological applications, most commonly for bioimaging 
and biosensing (42-45) as fluorescent probes for pathogens (42, 45) and chemo-sensors for 
concentration for glucose or oxygen (43, 44). Fluorescent polymers are also being used as 
carriers for delivery of drugs (40, 46-48) and as fluorescent molecular thermometers. Wu et al. 
synthesized a spectrum of highly fluorescent conjugated polymer dots for fluorescence imaging 
in live cells (49). However, the above mentioned fluorescent polymers need conjugation with a 
dye or quantum dots to exhibit fluorescence and each of these are associated with limitations, as 
mentioned previously.  
A newer, more easier and economical method is to polymerize the monomer by using a 
fluorescent initiator, thus the conjugated system is incorporated in the backbone of the polymeric 
chain (41). However, since these polymers do not degrade, they are not suitable for biomedical 
applications like tissue engineering. We know that biodegradation is a useful parameter for 
scaffolds constructs used in tissue engineering because it facilitates the ingrowth of newly 
formed tissue. An example of such biodegradable fluorescence emitting polycaprolactone (PCL) 
was synthesized by Zhang et al. using difluoroboron dibenzoylmethane (50) as an initiator, but 
its behavior with cells both in vitro and in vivo are unknown. 
Newer classes of fluorescent polymers are the fluorescent dendrimers containing a 
tetramine group, like poly (amido amine), (PAMAM), poly (ethyleneliamine)(PEI) etc, where 
conjugated tertiary amino group seems to be responsible for fluorescence (41).  
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2.2 INJECTABLE BIOMATERIALS 
Tissue engineering is a highly promising approach for regeneration of tissues like bone 
and teeth lost due to trauma and infection. Use of injectable scaffolds, which are bioactive 
molecules or cells with solidifiable precursors, to inject cells and/or growth factors directly into 
the defect results in formation of a three-dimensional structure in situ (51). These scaffolds are 
attractive in comparison to pre-formed scaffolds because they can easily be injected and fill 
irregularly shaped defects and wounds with easy manipulation and minimally invasive 
procedures, as well as cause less patient complications and discomfort (51-53). Also they 
solidify by an in situ mechanism and can be injected in any irregular sized defect without the 
need for prefabrication. Since the material is injectable; it eliminates the need for surgical 
interventions (51). The injectable scaffolds serve as ideal carriers for delivery of cells and 
bioactive molecules since it is much easier to incorporate these in a solution or suspension. 
2.2.1 Materials used as injectable scaffolds 
A variety of materials have been proposed for use as injectable scaffolds. These can be 
derived from natural sources or can be synthetically made in the laboratory. The natural 
polymers, derived from natural resources mimic properties of natural ECM and have the 
advantage of being easily recognized by the biological environment (54, 55). They are highly 
biocompatible, biodegradable and do not cause inflammatory or immune responses (55). 
Examples are collagen, gelatin, chitosan, hyaluronic acid, alginate, fibrin etc. However, there are 
concerns with these materials regarding pathogen transmission and availability in insufficient 
amounts for clinical applications. This has led to vast research in the field of synthetic polymers 
as substitutes to natural derived polymers for tissue engineering.  
The properties of synthetic biomaterials can be easily tailored to demands of clinical 
applications. Also, they can be manufactured on a large scale. These include Poly-ethylene 
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glycol (PEG), Poly(α-hydroxyesters) like (PLA, PGA, PLGA), Poly(N-isopropyl acrylamide), 
pluronic block copolymers etc.  
The third category of materials is based on ceramics and is also widely being used 
especially for bone tissue engineering. Ceramic materials are compounds of Ca2+ and PO4
3- ions 
in varying proportions and include hydroxyapatite (HA) Hydroxyapatite (HA) (56, 57), tri-
calcium phosphate (β-TCP) and calcium phosphate cements (CPC) (58-60). These inorganic 
materials could be used alone or can be blended with polymeric matrices, and are called hybrid 
materials. The blends are beneficial because they combine optimal properties of both the groups.  
A new class peptide based materials called self-assembling peptides (SEPs) are gaining 
interest for tissue engineering and protein delivery in the past few years. These are physically 
cross linked structures which undergo gelation by non-covalent self-assembly mechanism (61, 
62) . Since the self-assembled structures have specific functions, this property can be exploited 
to synthesize synthetic molecules for different tissue regeneration and drug delivery applications 
(63). 
2.2.2 Requirements of injectable scaffolds 
Injectable hydrogels should be maintained as a liquid before injection, but form a gel 
structure upon contact with body fluids. Additionally, the liquid solution can also be 
incorporated with growth factors (e.g., TGF and BMP) and cells (e.g., mesenchymal stem cells) 
(64). The injectable hydrogels and any additives like initiators, cross-linkers should be non-toxic 
before, during and after injection (65). The gel should have mild solidification conditions, such 
as neutral pH and physiological temperature (66). Moreover, the material, its components and 
any degradation products must be biocompatible i.e., they should not elicit an unresolved 
inflammatory response nor demonstrate extreme immunogenicity. Scaffolds should also possess 
sufficient mechanical strength to withstand biomechanical loading and provide necessary 
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support for the cells, and should match those of the tissue at the site of implantation (67, 68). The 
mechanical integrity of the scaffolds mainly depend on the original rigidity of polymer chains, 
types of crosslinking molecules and the cross-linking density, and swelling as result of 
hydrophilic/hydrophobic balance (66, 69-72). The mechanical properties may be improved  by 
incorporating particles of ceramic materials, such as β-tricalcium phosphate, hydroxyapatite, (66, 
73), and by incorporating nanofibers etc. into the hydrogels (74). 
Of the most critical and challenging issues in tissue engineering is the biodegradation of 
scaffold biomaterials. Ideally, degradation of scaffolds should match the rate of new tissue 
formation (75). The hydrogels can be degraded by three mechanisms - simple dissolution, 
hydrolysis, or enzymatic cleavage (66, 67, 76, 77), of which hydrolytic degradation is the most 
common mechanism (77). The key factors that determine the degradation rate are polymer type, 
the nature of crosslinking, cross-linking density, molecular weight, morphology, porosity, and 
amount of residual monomer (67, 68, 78, 79). Other factors, such as the local pH and 
incorporation of filler, may also play a role (80, 81). 
2.2.3 Types of injectable scaffolds  
Most common type of injectable scaffolds are the hydrogels which are soft and elastic 
polymers that form highly cross-linked three-dimensional water insoluble networks (40, 72, 82, 
83). These are relatively low-viscosity aqueous solutions (sol state) prior to injection, but rapidly 
convert into gel (gelation) by crosslinking of adjacent polymer chains. These can be classified 
based on the method of crosslinking into physical hydrogel and chemical hydrogel. 
Physically cross-linked hydrogels are formed by self-assembly of polymer chains which 
occur by a change in environmental conditions, such as temperature (chitosan, gelatin, and 
synthetic PNIPAAm , pluronic); ionic concentration; or pH etc. (84-86). The polymer chains are 
linked by physical forces like hydrogen bond (PEG/PAA inter-penetrating polymer networks 
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(IPN)) (87), ionic bond (alginates) (88), or hydrophobic or van der Waals interactions. In 
contrast, in chemically cross-linked hydrogels, covalent bonds are formed between different 
polymer chains through some type of reaction between adjacent functional moieties including  
disulfide bond formation, or reaction between thiols and acrylate or sulfones (85). External 
cross-linking agents most commonly glutaraldehyde can also be used for crosslinking amine-
based polymer chains as well as hydroxyl group or carboxyl group of polyvinyl alcohol (89), 
gelatin (90), partially acetylated chitosan (91), or hyaluronic acid (92). 
Another form of injectable scaffold is microspheres which are small particles of size 
(approximately between 1 and 1000µm) so that they can be injected through a syringe. These 
microspheres are synthesized from polymers like biodegradable aliphatic polyesters, which offer 
advantages of good mechanical properties, low immunogenicity and toxicity, and an adjustable 
degradation rate (93). The microspheres are widely being used as injectable vehicles for delivery 
of drugs, proteins, growth factors (93, 94) and injectable scaffolds in tissue engineering for three 
dimensional biomimetic cellular growth and guidance (95, 96).  
There are several techniques utilized for the preparation of microspheres, such solvent 
evaporation (single or double emulsion solvent evaporation), spray drying technique, hot melt, 
solvent removal, and phase inversion microencapsulation (97-100). Solvent evaporation method 
is the most common method. 
The microspheres can be either dense or hollow (101), and can be single-walled or 
multi-walled microspheres (102). Double or multi-walled microspheres have been developed to 
provide specific drug release properties, e.g., pulsed release, which could not be obtained by 
single walled-microspheres. Liu et al. synthesized nanofibrous hollow microspheres from star-
shaped biodegradable PLLA and used it as an injectable cell carrier for cartilage regeneration in 
critical-size rabbit osteo-chondral defects (52). It is also possible to alter the size of the 
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microspheres by various techniques. Factors that could affect the particle size include the 
polymer content, molecular weight, sonication time, concentration of surfactant content (103). It 
has been found that microsphere size has a significant effect on drug release rate, and that the 
release rate decreases with an increase in microsphere size. Therefore, sphere sizes can 
potentially be varied to design a controlled drug delivery system with desired release profiles 
(104). 
2.2.4 Development of advanced injectable scaffolding system 
Incorporate bioactive molecules in injectable scaffolds 
Some hydrogels that are made of non-cell interactive materials can be modified by 
incorporating cell membrane receptor ligands into the hydrogel matrix to improve their 
biofunctionality and therefore, guide cell differentiation, proliferation and migration. Alginate 
was covalently modified with an RGD peptide containing the amino acid sequence arginine-
glycine-aspartic acid (Arg-Gly-Asp) (105), and that peptide-modified alginate showed improved 
osteoblast adhesion and spreading (106, 107). The Anseth group has developed a RGD with a 
spacer arm sequence covalently tethered to the PEG network as a pendent functionality, which 
gave higher survival rate of human mesenchymal stem cells than that survival seen with dually 
attached RGD  (107, 108). PEG hydrogels have been modified by the Hubbell group and many 
others, with a variety of bioactive molecules to mimic the natural ECM, and to modulate specific 
cellular responses, such as cell adhesion, enzymatic degradation, and signal molecule-binding 
(109-112). 
Cell-instructive scaffolds 
Lutolf et al. engineered PEG hydrogels containing a combination of cell adhesion 
ligands (RGDSP) and substrates for matrix metalloproteinase (MMP) as linkers between PEG 
chains for delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2) to 
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regenerate bone (113). Other bioactive molecules that enable interactions with cationic amino 
acids of proteins, such as growth factors, cytokines and cell adhesion molecules such as 
polysaccharides- HE800 (hyaluronic acid-like polysaccharide) and GY785 (GAG-like polymer) 
have also been explored to be beneficial for bone and cartilage tissue engineering (114).  
Nanofibrous microspheres 
Development of 3D nanofibrous PLLA (NF-PLLA) scaffolds is another step toward 
mimicking the ECM (115). Liu et al. has developed nanofibrous hollow microspheres self-
assembled from star-shaped poly (L-lactic acid) (SS-PLLA), exhibiting the extracellular-matrix-
mimicking architecture. These nanofibrous hollow microspheres were successfully used as an 
injectable cell carrier for chondrocytes and showed a significant improvement in  cartilage repair 
compared to the group that used  chondrocytes only (116).  Also, a thermally induced phase 
separation method with porogen leaching was used to prepare three dimensional nanofibrous 
gelatin scaffolds (3D-NF-GS) and to mimic the physical architecture and chemical composition 
of natural bone ECM. Incubation of 3D-NF-GS with bone-like apatite showed enhanced pre-
osteoblast cell differentiation (117). 
2.2.5 Applications of injectable scaffolds in dental and craniofacial tissue regeneration 
Injectable scaffolds are widely being used for regeneration procedures in dental and 
craniofacial tissues. These are excellent carriers for pulp and dentin regeneration owing to 
small size and limited access to these defects. Also, they are promising candidates for 
scaffolding materials in research studies related to de novo pulp and dentin regeneration. In these 
methods, the pulp stem cells are seeded into an in vitro scaffold and inserted into the empty canal 
space to allow for de novo growth and differentiation of cells (118-120). The stem cell lines that 
have been used for dentin/pulp regeneration include the postnatal dental pulp stem cells (DPSCs) 
(121, 122), stem cells from exfoliated deciduous teeth (SHED) (123), periodontal ligament stem 
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cells (124, 125), stem cells from apical papilla (SCAP) (126-128) and dental follicle progenitor 
cells (129, 130). DPSCs, SHED and SCAP are potentially more suitable cell sources for 
pulp/dentin regeneration because they are derived from pulp tissue or the precursor of pulp 
(118). 
Periodontal or alveolar bone regeneration has shown improvement in in vivo studies 
with injectable materials incorporated with growth factors like PDGF, IGF, TGF, and 
recombinant human growth / differentiation factor-5 (rhGDF-5) to the scaffolds (MSC) (131-
134). Ji et al. used this novel hydrogel of chitosan and quaternized chitosan by mixed with α-β 
glycerophosphate (α-β GP)( CS-HTCC/GP) as an injectable local carrier of drug the 
ornidazole(135) and human periodontal ligament cells (HPDLCs) and growth factor (136) for 
periodontal treatment in vitro and in vivo, respectively. Addition of HTCC slowed the drug 
release and improved its biocompatibility. In vivo injection of hydrogel with HPDLCs 
significantly enhanced their proliferation. Conjugation with bFGF further improved the 
regeneration potential.  
Restoration of craniofacial bone and cartilage defects is very challenging and 
represents a substantial clinical problem of both medical and engineering concern. Various 
hydrogel polymer systems have been evaluated and appear promising as injectable scaffolds for 
delivery of cells, growth factors and bioactive molecules for craniofacial bone defects. Burdick 
et al. (137) attached adhesive Arg-Gly-Asp (RGD) peptide sequences to non-adhesive PEG 
hydrogels and photoencapsulated rat calvarial osteoblasts in these gels. The cells showed 
improved cell adhesion, spreading and mineralization compared with controls. Zhao et al. 
developed a composite injectable scaffold construct of CPC paste and alginate microbeads and 
encapsulated the human umbilical cord mesenchymal stem cells (hUCMSCs) for regeneration of 
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bony defects (138). This system was mechanically sound for load bearing and also enhanced 
osteogenic expression markers. 
Other common anomalies of craniofacial regions are the craniosynostotic defects 
occurring in newborns. The Tgfs play an essential role in bone biological processes including 
suture patency and fusion. Due to short half -life of TGF-β3, slow and continuous release 
systems levels of TGF-β3 levels are ideal for suture patency. Studies by Opperman and group 
have shown that the patency of sutures can be maintained for upto 12 weeks by delivery of TGF-
β3 through slow resorbing collagen gel at the suture site (139, 140). In a similar context, Moioli 
et al. developed a sustained release injectable system of TGF-β3 encapsulating PLGA 
microparticles. The release kinetics showed that TGF-β3 release was maintained even after 7 
weeks.  Bioactivity of TGF-β-PLGA microspheres cultured in vitro with the hMSCs was verified 
by reduced ALP activity and inhibition of osteogenic differentiation of the cells (141). 
2.3 GOAL OF THE RESEARCH 
Our previous study has shown that the NF PLLA microspheres are excellent cell carriers 
for tissue regeneration.  However, these injectable microspheres are not fluorescent biomaterials. 
Therefore, they cannot be accurately tracked during injection and the later degradation without 
using invasive procedures such as tissue dissection and immunohistochemistry. By incorporating 
fluorescent chromophores into NF PLLA microspheres, it will allow imaging for proper delivery 
of scaffold at the specified site and to monitor the time related degradation changes in the 
scaffold as well tissue regeneration by live fluorescent imaging, without the need of sacrificing 
the animals or undertaking elaborate histological procedures (142-144).  To date, there is no 
report on the synthesis of fluorescent PLLA. 
In this research, we aim to develop an injectable fluorescent PLLA scaffold for tissue 
regeneration. We will synthesize novel fluorescent PLLA by using a fluorescent initiator, 
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fabricate it into fluorescent nanofibrous microspheres, and evaluate this novel fluorescent 
biomaterial as an injectable scaffold in vitro with the dental pulp stem cells (DPSCs). 
2.4 AIMS OF THE RESEARCH 
The following are the aims of the current study- 
 Aim 1: Synthesis of fluorescent PLLA polymer initiated with a fluorescent initiator 
and its characterization   
 Aim 2:  Fabrication of microspheres (smooth walled and nanofibrous) from the 
fluorescent PLLA polymer initiated with fluorescent initiator and its characterization 
2.5 HYPOTHESIS 
The following are the hypothesis set for the study- 
 Hypothesis 1: Polymerization reaction of lactide with fluorescent initiator will 
result in formation of an auto-fluorescent biodegradable polymer. 
 Hypothesis 2: The auto-fluorescent polymer will be successfully used for 
fabricating nanofibrous microspheres with high quality fluorescence. 
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3. SYNTHESIS OF THE FLUORESCENT POLYMER AND 
ITS CHARACTERIZATION 
 
3.1 MATERIALS AND METHODS 
For synthesis of the fluorescent polymer, the l-lactide monomer was first recrystallized 
to remove any impurities. It was polymerized in bulk by ring opening polymerization (ROP) in 
the presence of a fluorescent initiator and a catalyst. The obtained crude polymer was dissolved 
in a suitable solvent, washed multiple times and finally air dried. 
The l-lactide monomer (3,6-Dimethyl-1,4-dioxane-2,5-dione) (≥98%) with a melting 
point of 49°C (120°F) was purchased from Sigma-Aldrich (Figure 1A). The catalyst was tin (II) 
2-ethylhexanoate 95% [aka Stannous octoate Sn(Oct)2] (Sigma-Aldrich) (Figure 1B) which is 
most commonly used catalyst for ROP. 
The fluorescent initiator was Eosin Y (EY) (2′,4′,5′,7′-Tetrabromofluorescein) (Sigma-
Aldrich). Eosin Y is a xanthene type fluorescent dye which has gained interest as a fluorescent 
material owing to its moderate electronic excited state (Es 53.16 kcal/mol) (145).  It is a reddish 
brown powder with a molecular weight of 647.89 g/mol and a melting point of 300oC (572oF) 
(146). The chemical formula is shown in Figure 1C. The optical absorption spectra of Eosin Y in 
basic ethanol solution shows a peak at 525nm and emits at about 544nm (147). It is soluble in 
ethanol (solubility 1mg/ml), methanol and acetone (147). It is insoluble in water but its 
potassium and sodium salts are water soluble. 
3.1.1 Recrystallization of lactide monomer 
Recrystallization of monomer is an important step to obtain high molecular weight 
polymer. For this process, first the l-lactide monomer (20 g) was dissolved in 15 ml of toluene 
(approx. 4:3 wt/wt%) by stirring on a hotplate at about 70°C.  The dissolved monomer was 
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Figure 1. Chemical structures of the materials used in ROP of l-lactide (148) 
 
 removed from the heat and quickly filtered through a Buckner funnel. It was allowed to cool at 
ambient temperature and then kept in to the refrigerator overnight (4oC) for crystal formation. 
This process was repeated one more time. The obtained crystals were dried for 24 hrs under 
reduced pressure and stored in vacuum in desiccator over copper sulphate (CuSO4) desiccant to 
avoid the absorption of water. 
3.1.2 Ring opening polymerization of l-lactide monomer 
As discussed in the literature review section, one way to polymerize the lactide is by ring 
opening polymerization. The monomer to catalyst molar ratio i.e. l-lactide to Sn(Oct)2was kept 
constant at 100:1 throughout the course of the polymer synthesis. However, the molar ratio of 
monomer to initiator (M/I) i.e. l-lactide to EY was altered. The following M/I ratios were 
synthesized depending on the requirement of the reaction- 20:1, 100:1, 200:1 and 400:1. 
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A double-neck round-bottomed flask was thoroughly washed and dried in the oven. L-
lactide and Eosin Y were weighed in the desired amounts and placed in the flask with a clean 
magnetic stirrer. The flask was sealed with a septa and copper wire and vacuum-evacuated 
overnight. The removal of water from the system is a critical step for obtaining high-molecular-
weight polymer since water, if present may act as a co-initiator. Sn(Oct)2 was dissolved in 
dichloromethane (DCM) solution and introduced into the flask using a syringe with a stainless 
steel needle under N2 purging. The DCM was later distilled under reduced pressure for about 30 
min. All the work was performed in a fume hood. 
The flask was conditioned in a silicone oil bath at 140°C for few minutes. The entire 
flask was then submerged in the silicone bath. Both the silicon bath and the monomer were 
stirred at 140°C overnight. After the polymerization was completed, the hot plate was turned off 
and the contents were allowed to cool down to room temperature (25°C). The obtained polymer 
was dissolved in dichloromethane (DCM) while stirring continuously. It was reprecipitated in 
cold methanol and then dissolved in DCM. This process was repeated about 3 times. The 
resultant powder / fibrous polymer were washed multiple times in absolute ethanol to remove 
unreacted EY and low molecular weight polymer. It was allowed to air dry for a couple of days 
before use.  The polymer was stored in dark under reduced pressure and in vacuum in a 
desiccator over CuSO4beads to avoid the absorption of water. 
3.2 METHOD FOR CHARACTERIZATION OF THE PLLA-EY POLYMER 
3.2.1 Fourier transform infrared spectroscopy (FT-IR) 
FT-IR spectra for PLLA, EY and the PLLA-EY polymer samples were recorded in the 
ATR mode with the help of Nicolet™ iS™10 FT-IR Spectrometer (Thermo Scientific) in the 
range of 4000 to 600 cm-1. This method determines the molecular structure of compounds based 
on their characteristic absorption of infrared radiation. DCM was used as a solvent for PLLA and 
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PLLA-EY in a concentration of 10mg/ml, whereas pure EY was dissolved in methanol. The 
sample drop was placed on the NaBr crystal pellet and the solvent was allowed to air dry. After 
proper background removal and baseline corrections the corrected the peaks were determined 
using Ominic software installed in the FTIR spectrometer. 
3.2.2 UV-visible spectroscopy 
With this method, the light absorption of a colored solution is measured at wavelengths 
in the near ultraviolet and visible portions of the spectrum. UV-visible spectrum measurement 
was done with a Cary Win 50 UV-Vis spectrometer. Firstly serial dilutions of EY were prepared 
(in ethanol) and a spectrum was taken to determine the absorbance peak of EY. Then, PLLA-EY 
polymer was dissolved in DCM and subjected to UV-visible spectral measurements. Corrected 
peaks were determined after proper background removal and baseline corrections.  
For 20:1 PLLA-EY polymer, UV-visible spectroscopy was done at 5 different 
concentrations (2mg/ml, 5mg/ml,. 10mg/ml,. 15mg/ml, 20mg/ml).The three polymers with 
different M/I ratios (20:1, 100:1, 200:1) were tested at the same concentration (10mg/ml).  
3.2.3 Gel permeation chromatography (GPC) for molecular weight determination 
Gel permeation chromatography (GPC) is a size exclusion chromatography, used to 
determine the molecular weight of the polymer samples. HPLC grade tetrahydrofuran (THF) was 
used as an eluent (mobile phase) at room temperature at the flow rate of 1 mL min-1 against 
polystyrene (PS) standards (stationary phase). 1gm polymer samples were dissolved in 1 ml of 
THF for complete dissolution. The columns were equilibrated and run at 30ºC, at a flow rate of 1 
ml/minute. A two-channel UV detector and a refractive index detector were used to analyze the 
sample data based on polystyrene standards. 
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Figure 2. Chemical reaction showing the ring opening polymerization (ROP) of l-lactide with 
Eosin Y initiator and the formation of PLLA-EY polymer 
 
3.3 RESULTS 
3.3.1 Predicted mechanism of ROP of lactide  
The chemical formulas and predicted chemical reaction and final PLLA-EY polymer is 
shown in the Figure 2. In the presence of Sn(Oct)2 catalyst and Eosin Y initiator, the ring 
structure of l-lactide opens up and EY gets incorporated in the l-lactide molecule. This is 
followed by chain propagation with addition of more l-lactide molecules to the polymer chain. 
3.3.2 Fourier transform infrared spectroscopy (FT-IR)  
FT-IR spectra of PLLA, EY and PLLA-EY 20:1 is presented in the figures below. The 
FT-IR curve of PLLA (Figure 3) looks similar to that described in previous studies. The spectra 
exhibited characteristic absorption peaks at 2996 cm-1 for −CH stretching, 1755 cm-1 for −C=O 
stretching, 1454 cm-1 for −CH3 bending, and  1181 cm
-1 for  −C−O−C− vibration.  
FT-IR spectrum of EY is shown in Figure 4. The peaks from 3500-3200 cm-1 are the 
absorption bands for –OH stretching. The band at 1749 cm-1 is assigned for −C=O stretching of a 
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Figure 3. FT-IR spectrum of PLLA showing absorption peaks (cm-1) 
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Figure 4. FT-IR spectrum of Eosin Y showing absorption peaks (cm-1) 
  
24 
 
 
 
Figure 5. FT-IR spectrum of PLLA-EY 20:1 showing absorption peaks (cm-1) 
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free carboxyl group. The peaks at 1462 and 1417 cm-1 are from C-C stretching in a ring and from 
CH3 bending.  
The curve for PLLA-EY 20:1 follows PLLA curve for most of the time, as seen in 
Figure 5, indicating that it’s a polymer of PLLA. However, the peak at 1748 cm-1 is very similar 
to that present in EY due to carbonyl stretching and indicates the presence of EY in the polymer. 
3.3.3 UV-visible spectroscopy 
Serial dilutions of EY solution (in ethanol) showed a peak at 524 nm indicating the 
absorbance wavelength of EY (R2=0.9974). 
Figure 6A represents the UV–visible spectrum of PLLA-EY polymer with different M/I 
ratio at same concentration (10mg/ml). The maximum absorbance was seen for 20:1 PLLA-EY 
(0.71; 538nm) and decreased gradually with increasing M/I ratio, indicating a decrease in the 
amount of initiator. A slight red shift was also observed with increase in M/I ratio. 
 
Figure 6. A) UV-visible spectrum of PLLA-EY with different M/I ratios at same concentration; 
B) UV-visible spectrum of PLLA-EY 20:1 at different concentrations 
A 
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Figure 6. Continued 
Figure 6B represents the UV–visible spectrum of 20:1 PLLA-EY polymer at different 
concentrations. The maximum absorbance was seen with 20mg/ml (0.9; 538 nm) and decreased 
with decreasing concentration of polymer, indicating a decrease in the initiator. A red shift was 
also observed with increase in M/I ratio compared to pristine EY.  
The above data indicates that firstly, the EY is present in the polymer and secondly, 
increasing the M/I ratio decreases the amounts on initiator in the polymer. 
3.3.4 Gel permeation chromatography (GPC) for molecular weight determination 
Retention times of different polymers with GPC are given in Table 1. The retention 
times (RT) of PLLA was 8.48, PLLA-EY 400:1 was 10.32 and for PLLA-EY 100:1 was 11.23. 
With PLLA-EY 200:1, a peak was seen at RT 10.9. Based on the RT, the molecular weights for 
PLLA was about 100K, PLLA-EY 400:1 was about 3000, PLLA-EY 200:1 was about 2100 and 
or PLLA-EY 100:1 was about 500. Very low molecular weights were obtained for the polymers  
B 
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Table 1. Retention times and molecular weights of the synthesized PLLA-EY polymers  
determined by GPC 
 
 
 
the molecular weight of 20:1 PLLA-EY was not calculated since the retention time   
would be higher than that of the standard curve that was prepared. 
3.4 DISCUSSION 
The PLLA be synthesized by two different routes – by polycondensation of α-
hydroxycarboxylic acids, for example lactic acid for PLLA (149) or by ring-opening 
polymerization (ROP) of cyclic diesters. In the polycondensation reactions, water is released as a 
byproduct which limits the molecular weight of the polymer, therefore ROP is usually the 
preferred method for synthesizing high-molecular-weight polymers as those desired for 
biomedical applications (149, 150). ROP method also allows for a greater control of the 
polymerization and for controlling the monomer  sequence and side chains (150). ROP can be 
done by using different initiators and it is also possible to obtain PLLA with different terminal 
groups.  The bulk polymerization of lactide is done using a catalyst, and most common one is 
Sn(Oct)2. Tin compounds are preferred for the bulk polymerization of lactide due to higher 
solubility in common organic solvents and in melt monomers. They also possess a high catalytic 
activity (reaction occurs in few hours) and lower rate of racemization of the polymer. The 
conversion rates are also high and high molecular weights polymers are formed (151).  Initiators, 
 
Retention time (RT) Molecular Weights 
PLLA-EY (400:1) 10.327 2938 
PLLA-EY (200:1) 10.5 2107 
PLLA-EY (100:1) 11.23 518 
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such as 1-dodecanol, glycerol and 1,4-butanediol (149) have been used for polymerization of 
polylactide. However, the synthesis of self-fluorescent polylactide by using florescent initiator 
has not been reported in the literature till date.  
In this study, the aim was to synthesize PLLA by ROP of lactide in the presence of 
Sn(Oct)2 catalyst and a fluorescent initiator-Eosin Y, based on a previous study (152). The 
polymerization of lactic acid in presence of Sn(Oct)2 catalyst occurs by a coordination-insertion 
mechanism (150, 153, 154) . Eosin Y contains one free hydroxyl group and one carboxyl group. 
The free hydroxyl group has the capability of initiating the ROP. Based on the previous studies 
on lactide polymerization, we believe that the –OH group on 3’position of EY acts as a site of 
initiation and generates a free radical. Two molecules of EY coordinate with Sn(Oct)2 and form 
covalent tin(II) alkoxides. This is followed by the coordination of lactide to the metal center. The 
insertion occurs in two steps- first, the nucleophilic attack of this alkoxide on the coordinated 
lactide and this result in ring opening of lactide. This causes the insertion of lactide to –OH 
group of EY, generating a linear monomer. The linear polymer then starts the chain propagation 
step.  
Molecular weight of the polymer is an important property which dramatically affects its 
physical characteristics. As mentioned in the polymer synthesis, the recrystallization of lactic 
acid is an important step to obtain high molecular weight PLLA. Presence of impurities like 
water, methanol, ethanol etc. in the monomer can act as co-initiators for polymerization and 
result in low molecular weight; therefore, it is very important to minimize the water content in 
the reaction system to control the molecular weight of the resulting polymer.  
Another way to control the molecular weight of the polymer is by altering the molar 
ratio of monomer to initiator  (155). In this study, the PLLA was synthesized by using a range of 
monomer to initiator molar ratios (M/I). As the M/I ratio increases, the molecular weight of the 
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polymer increases, as seen in previous studies. The reason in that lower initiator amount results 
in less initiation sites for lactide attachment, so during chain propagation step, more lactide 
continue to attach to the same chain, resulting in high molecular weight polymer. In the current 
study, PLLA EY 100:1 had the lowest molecular weight, whereas 400:1 had the highest 
molecular weight.  It was also seen that the physical form of 20:1 polymer was in form of a 
powder, and as the M/I ratio increased, the polymer became more fibrous looking, as seen in 
previous studies. This observation also supported the increase in molecular weights of the 
polymer, as obtained from GPC.  
The molecular weights of the polymers synthesized in the current study were on the 
lower side than expected. Although the low molecular should not be an issue considering the 
clinical use of this polymer in pulp tissue regeneration, high molecular weights are desirable for 
polymer scaffolds used for bone and cartilage regeneration. Further studies should concentrate 
on obtaining high molecular weight PLLA-EY polymers by controlling the purity of both the 
lactide monomer and initiator and by standardizing the polymerization reaction conditions like 
temperature, pressure, polymerization time etc. 
The FTIR of 20:1 showed a slight peak due to presence of Eosin Y in it at 1749cm-1. The 
FT-IR was also run for other polymers (100:1, 200:1, 400:1) but the curve was similar to PLLA 
and detection of EY could not be done by IR spectroscopy. This does not mean that Eosin Y was 
not incorporated in these polymers, but it can be concluded that the electron vibration method for 
detection was not sensitive enough to detect the EY through FTIR. For the same reason, UV 
spectrometry was done for detection of EY in the polymer and the absorption peaks of EY seen 
in the UV spectra confirmed the incorporation of EY in the PLLA polymer. 
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4. FABRICATION OF MICROSPHERES FROM FLUORESCENT PLLA-EY  
POLYMER AND THEIR CHARACTERIZATION 
 
4.1 MATERIALS AND METHODS 
The PLLA-EY polymers (PLLA-EY 200:1 and 400:1) were used for synthesis of two 
types of microspheres- smooth-walled (SW) and nanofibrous (NF). The aim of this experiment 
was to synthesize and characterize the microspheres and compare the differences between the 
two types of polymers and two types of microspheres in terms of their architecture, cellular 
attachment ability and biodegradation.  
4.1.1 Synthesis of smooth-walled (SW) microspheres 
Emulsification/solvent-evaporation method was used for preparation of SW PLLA-EY 
microspheres according to the previous report (52). PLLA-EY was first dissolved in 
dichloromethane (DCM) at room temperature with a concentration of 2.0% (wt/v). This PLLA-
EY solution was then slowly added drop-wise to 10-fold volume of PVA solution (2.0% (wt/v)) 
stirring at a speed of 300-600 rpm. The mixture was then continuously stirred overnight at room 
temperature. Once the DCM had evaporated completely, the resultant microspheres were sieved, 
washed with water, and finally freeze-dried. Microspheres in the size range of 20-60µm were 
used for further characterization. 
4.1.2 Synthesis of nanofibrous (NF) microspheres 
The NF microspheres were synthesized according to the protocol followed by Liu et al. 
(52). The PLLA-EY polymer was dissolved in tetrahydrofuran (THF) at 50°C in a concentration 
of 2.0% (wt/v). Under rigorous mechanical stirring at 500 rpm, glycerol (50°C) with 2.5 times 
the volume of the polymer-THF solution was gradually added into it, and stirred for 2-3 min 
afterwards. The mixture was then quickly poured into liquid nitrogen for flash freezing and 
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formation of nanofibers. After 10 min, a water-ice mixture (1L) was added for solvent exchange. 
The spheres were sieved, rinsed with distilled water, and finally freeze-dried. Microspheres in 
the size range of 20-60µm were sorted by sieving and used for further characterization. 
4.2 METHOD FOR CHARACTERIZATION OF MICROSPHERES 
4.2.1 Scanning electron microscopy (SEM) 
The surface morphology and architecture of the microspheres was observed by SEM 
(JSM-6300). The freeze dried microspheres (20-60µm) were lightly sprinkled on the SEM stubs 
with a double sided adhesive carbon tape. The samples were first coated with gold (20mA, 50 
mtorr) for 120 seconds and then analyzed under the SEM at 12-15 kV. 
4.2.2 Confocal microscopy 
The microspheres were analyzed for auto-fluorescence using a Leica SP5 confocal 
microscope equipped with an apochromatic 63x objective (0.9 N.A.).  A small amount of sample 
was placed on a glass slide with a drop of oil or water and placed under the objective. The 514 
nm Argon laser (~50% power) was used to excite the Eosin Y dye present in the polymer. 
Various z stacks and slices were acquired for the samples.  The z-stacks were acquired for the 
entire depth of the microspheres (20-60 µm) and projected into 2D images. Multiple samples 
were analyzed for each type of polymer, and the images were taken. 
4.2.3 In vitro cytotoxicity testing (MTS assay) 
Cytotoxicity was assessed using 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. The aim was to 
determine if there are differences in cell viability between the dental pulp stem cells (DPSCs) 
cultured in presence/absence of PLLA-EY microspheres. The DPSCs (Passage 2) were a 
generous gift from Dr. Songtao Shi (University of Southern California, CA). These cells were 
allowed to proliferate to passage 5 and were seeded on 96-well tissue culture polystyrene (TCPS) 
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plates at a density of 6000 cells/well (3000 cells for 21d) for 24 hrs. Microspheres (SW and NF) 
from PLLA-EY 200:1 were pretreated with alcohol for an hour and washed twice in PBS before 
adding them to the cells in the wells, with a density of 1000 microspheres per well. Cells 
cultured without microspheres served as controls. Thus 6 groups were formed- NF-MS, SW-MS, 
NF-Cells, SW-Cells, Cells (DPSC) only and culture medium.  
The microplates were cultured in α-MEM supplemented with 10% fetal bovine serum 
(FBS) containing 1% Pen-Strept antibiotics (Gibco, USA). They were kept on a plate shaker (50 
rpm) under humid atmosphere at 37°C with 5.0% CO2 for 1, 3, 7 and 21 days. Triplicates were 
used for each group. The media was changed every other day. The cell viability was assessed 
using a MTS assay kit (CellTiter 96® Aqueous One Solution Cell Proliferation Assay, Promega, 
Madison, WI, USA).  For this assay, the media was replaced by 1ml of fresh media and to this, 
200 µl MTS solution was added, this was incubated in a cell-culture incubator for 2.5 hrs. The 
absorbance was measured at 490 nm using a 96-well microplate reader. The absorbance of the 
microspheres only group (NF and SW) was subtracted from their respective microsphere-cell 
group (NF-Cells, SW-Cells) to omit any effects the Eosin Y dye might cause on the absorbance. 
The cell viability was normalized against the culture of 1 day DPSCs. Statistical analysis was 
done to determine if  significant differences existed between the 3 groups (NF-Cells, SW-Cells, 
Cells only) at each time point by one way ANOVA. P-value of < 0.05 was considered to be 
statistically significant.  
The light microscopy images of the 21 day samples were taken at various magnifications 
with a camera attached to the microscope. 
4.2.4 Biodegradation of microspheres  
The biodegradation of microspheres was tested in vitro for PLLA-EY 400:1 polymer. 
Two groups were formed- NF-MS and SW-MS. These were analyzed for biodegradation at three  
Reference or explanation? 
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Figure 7. SEM images for SW microspheres prepared with PLLA-EY 200:1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. SEM images for SW microspheres prepared with PLLA-EY 400:1 
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time points- 1wk, 3 wk and 6 wks. 
About 15 mg of microspheres from each group were placed per vial in the 1 ml plastic 
vials and to this; 1 ml of PBS solution (0.01 M, pH 7.4) was added. Triplicates were prepared for 
each time point. The PBS was changed every 3 days, and the supernatant was collected for 
testing the pH every 3 days initially and then every week thereafter. At 1, 3 and 6 weeks, the 
microsphere samples were taken out. These were rinsed with deionized water and freeze dried. 
The SEM images were taken with the method described before. 
4.3 RESULTS 
4.3.1 Scanning electron microscopy (SEM) 
SEM images for SW microspheres prepared with PLLA-EY 200:1 and PLLA-EY 400:1 
are shown in Figures 7 and 8. Both the polymers formed microspheres that were spherical, 
smooth walled and most of the microspheres were in the desirable size range of 20-60µm. No 
differences were seen between the polymers in terms of surface smoothness and architecture of 
the microspheres.   
NF microspheres prepared with PLLA-EY 200:1 shows that it was able to form 
microspheres in which nanofibrous architecture was just beginning for form (Figure 9A). The 
surface of the microsphere was highly porous but distinct nanofibers were not seen (Figure 9B).  
In comparison to this, the PLLA EY 400:1 formed microspheres with well-defined and 
nanofibrous architecture, as seen in Figure 10(A, B). 
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Figure 9. A) SEM images for NF microspheres prepared with PLLA-EY 200:1; B) SEM image 
of a single NF microsphere prepared with PLLA-EY 200:1 
A 
B 
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Figure 10. A) SEM images for NF microspheres prepared with PLLA-EY 400:1; B) SEM image 
of a single NF microsphere prepared with PLLA-EY 400:1  
B 
A 
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4.3.2 Confocal microscopy 
The confocal images of SW microspheres prepared with PLLA-EY 200:1 and PLLA-EY 
400:1 are shown in Figures 11 and 12, respectively. From the images, it can be seen that the 
microspheres are auto-fluorescent and the fluorescence is in the emission range of EY, indicating 
that EY has incorporated into the PLLA polymer. No differences are seen in the SW 
microspheres from both the polymers. 
 
 
Figure 11. Confocal image of smooth walled microspheres prepared with PLLA-EY 200:1 
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Figure 12. Confocal image of smooth walled microspheres prepared with PLLA-EY 400:1 
 
The confocal images of NF microspheres prepared with PLLA-EY 200:1 and PLLA-EY 
400:1 are shown in Figures 13 and 14, respectively. It can be seen that the microspheres are 
auto-fluorescent and the fluorescence is in the emission range of EY, indicating that EY has 
incorporated into the PLLA polymer. On comparing both the polymers, the outer boundary of 
microspheres prepared from PLLA-EY 400:1 appears more porous and ragged, and the 
microsphere surface is more intricate, indicating a more nanofibrous architecture compared to 
the PLLA-EY 200:1. 
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Figure 13. Confocal image of a single nanofibrous microsphere prepared with PLLA-EY 200:1 
 
 
 
 
Figure 14. Confocal images of nanofibrous microspheres prepared with PLLA-EY 400:1  
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4.3.3 In vitro cytotoxicity testing (MTS assay) 
Cells continue to proliferate even in presence of PLLA-EY microspheres (Figure 15). At 
day 3, the number of cells increases two-fold compared to day 1. At day 7, there is a 4.5 fold 
increase in cell number, and this continues to a 7-8 fold increase at day 21. At day 21, the cell 
viability in the presence of NF microspheres (NF-cell group) and SW microspheres (SW-cell 
group) is higher than the DPSC only group. This indicates that the presence of microspheres 
around the cells supported cell growth. The cell viability in the NF group was more than in the 
SW group; this supports the idea that NF microspheres provide a more biomimetic 3D 
environment for cell growth, as has been shown in previous studies. 
The percent cell viability at day 7 and day 21 for the both the microsphere containing 
groups were higher than the cell only group. Also, at day 21, the NF-cell group had higher 
viability values compared to the SW group indicating a higher growth of cells on the NF 
microspheres compared to the SW microspheres. However, no significant differences were seen 
in the cell viability values at day 1 (ANOVA, p=0.054), day 3 (ANOVA, p=0.08), day 7 
(ANOVA, p=0.63) and day 21 (ANOVA, p=0.12). 
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Figure 15. Percent viability graph of DPSCs determined from the MTS cytotoxicity assay. Error bars indicate standard deviations 
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Figure 16. Light microscopy images of MTS assay of PLLA EY 200:1 at day 21. Red arrows indicate DPSCs A) DPSC only (20x);  
B) Cells attached around SW microspheres (20x); C) Cells attached to NF microspheres (20x); D) Higher magnification of C (40X) 
showing aggregated microspheres and cell attachment on them
The light microscopy images of the MTS assay (day 21) are seen in Figure 16. The cells 
are attached on microsphere surface (both SW and NF) in the microsphere-cell group. Most NF 
microspheres formed aggregates due to cell adhesion around and between the microspheres 
(Figure 16 C, D), something which was not observed in the SW group (Figure 16B). 
4.3.4 Biodegradation of microspheres 
No change in pH values was seen in the supernatant solutions collected from the 
biodegradation study. No differences were seen in the pH values between SW and NF 
microspheres (Figure 17). Around day 70 however, it was observed that the pH values of NF 
microspheres slightly decreased as compared to the SW microspheres. 
 
 
 
 
Figure 17.pH values of PBS samples collected from in vitro biodegradation of NF and SW 
microspheres 
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The SEM images of SW microspheres collected from biodegradation experiment are 
shown in Figure 18.  No differences were seen in the microspheres incubated for 1, 3 weeks 
(Figure 18A,B) and 6 weeks, indicating that the disintegration of microspheres had not started 
even at the end of 6 weeks immersion in PBS solution (Figure 18C).  
The SEM images of NF microspheres collected from biodegradation experiment are 
shown in Figure 19.  There was no change in the microspheres incubated for 1 week and 3 weeks  
 
 
Figure 18. SEM images of biodegradation of SW microspheres incubated in PBS solution for  
A) 1 wk; B) 3 wks; C) 6 wks 
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(Figure 19A, B), but at 6 weeks of incubation in PBS solution, some microspheres retained their 
original spherical shape while in some areas, microsphere disintegration was seen with broken 
down microspheres and debris in the vicinity (indicated by red arrows in Figure 19C), indicating 
that the biodegradation process had started taking place in the NF microspheres. 
 
 
 
Figure 19. SEM images of biodegradation of NF microspheres incubated in PBS solution for  
A) 1 wk; B) 3 wks; C) 6 wks. Red arrows indicates debris from microsphere biodegradation  
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4.4 DISCUSSION 
The second aim of the current study was to synthesize microspheres from the fluorescent 
PLLA-EY polymer described in the previous chapter. Two polymers were used for microsphere 
synthesis- PLLA-EY 200:1 and 400:1. It is important to note that the molecular weights of 
polymers PLLA-EY 20:1 and 100:1 were too low to be able to form microspheres. Also, higher 
initiator content might mean greater cytotoxic effects, which we wanted to optimize.  It has been 
observed that the appropriate size of microspheres for injectability for clinical use is about 25-
60µm, so further characterization of microspheres was done using microspheres of this size 
range.  
A thermally induced phase separation technique (TIPS) that has been described 
previously (156-159) and used for microparticle synthesis by Liu et al. (52), was used for 
synthesis of microspheres. The TIPS is a liquid-liquid phase separation technique developed by 
Ma et al (157). This technique yields PLLA matrix with fiber length ranging from 50-500nm and 
involves polymer dissolution, phase separation and solvent exchange, freezing and freeze-drying 
(160, 161). In context with the current study, the PLLA-EY was first dissolved in THF solvent. 
Addition of glycerol to this mixture while stirring vigorously led to phase separation and 
formation of a polymer rich phase formed from PLLA-EY microspheres and a polymer lean 
phase formed by the solvent, as described previously (162). The speed of the mechanical stirrer 
was optimized to obtain a higher yield in the desirable size range. Rapid pouring of this mixture 
into liquid N2 caused flash freezing with formation of nanofibrous architecture in the 
microspheres  (157). The solvents were exchanged with water-ice mixture and then the 
microspheres were freeze-dried. These NF scaffolds are highly desirable in tissue engineering 
since they mimic the physical architecture of natural extracellular matrix (ECM) and are highly 
superior to SW scaffolds in promoting cell migration, attachment, proliferation and 
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differentiation for tissue engineering (163-165). The additional benefit of using nanofibrous 
microspheres in tissue engineering is that they are also injectable owing to their micron size. 
Differences in architecture were seen between nanofibrous microspheres synthesized 
from PLLA-EY 200:1 and 400:1 by SEM and confocal microscopy. The 400:1 polymer formed 
highly well-defined nanofibers, similar to those formed by PLLA in previous studies (116, 157). 
However, in the 200:1 polymer, the nanofibers were partially formed or just starting to form. 
These differences can be explained by the different molecular weights of the two polymers with 
PLLA-EY 400:1 being of higher molecular weight. According to the principle of nanofibers 
formation, the molecular weight of a polymer is an indicator of the polymer chain entanglement 
in the solution. At the same polymer concentration, lowering the molecular weight causes 
formation of beaded structures while increasing the molecular weight tends to form smooth 
fibers  (166). Thus, an increase in molecular weight of the polymer is associated with formation 
of more well defined nanofibers, as seen in the 400:1 polymer. Microspheres were also 
attempted to be synthesized from the 100:1 polymer but microspheres could not be formed due 
to its very low molecular weight. 
The MTS assay for cell viability tested the cytotoxicity of EY on DPSCs. The 
microspheres from PLLA-EY 200:1 were used, since this polymer incorporated more initiator 
than the 400:1 polymer. The microspheres were first pretreated with alcohol for pre-wetting and 
washed twice in PBS before they were mixed with the cells. For the 21 day culture, number of 
seeded cells were reduced to half compared to other groups, because long term culture with more 
cells could cause cell death from over-confluence or  insufficient nutrition which could be 
confused with cell death caused by EY. The results showed that at day 21 in culture, the percent 
viability of DPSCs for the NF-cell group > SW-cell group > DPSC only group. Also, in the NF-
cell group, small aggregates of microspheres were formed, with cellular processes of DPSCs 
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extending between the adjacent cells and microspheres. These findings resulted from the higher 
surface area of nanofibrous architecture, which favors cellular adhesion, proliferation, migration 
and differentiation (164, 165, 167, 168). It would be interesting to evaluate the cell migration 
and ell-cell and cell-scaffold interaction on the scaffolds by evaluating gene expression. 
Biodegradation is an important property of the scaffolding material that needs 
consideration in tissue engineering. Ideally, a scaffold should disintegrate at the right rate to 
match the new tissue formation. The biodegradation process of PLLA involves hydrolytic attack 
of the ester bond with formation of lactic acid and an alcohol. The biodegradation properties are 
affected by a variety of intrinsic and local factors like crystallinity, molecular weight, polymer 
concentration, hydrophobicity, temperature, presence of enzymes etc (169-171). In the presence 
of water, the polymer rapidly plasticizes and ultimately leads to mechanical distortion and 
fracture of the polymer. One way to characterize the degradation of PLLA is by measuring the 
pH since lactic acid is released upon its degradation. Also, because of the porous architecture the 
NF microspheres are expected to degrade faster than SW microspheres. In the current study, not 
much difference was seen in the pH between the two groups. However, the SEM images showed 
that the biodegradation of NF PLLA-EY microspheres had started by 6 weeks in vitro, whereas 
no biodegradation was seen in the SW PLLA-EY microspheres. This time point should be 
suitable for the microspheres to be used for application of pulp tissue regeneration. However, the 
factors that cause biodegradation in vivo are very different than in vitro and evaluating the 
biodegradation process in vivo needs to be a part of future research. 
Future studies are needed to evaluate the cell adhesion, proliferation and differentiation 
of DPSCs by gene expression on these fluorescent microsphere scaffolds. It would also be 
interesting to inject these microspheres in vivo with the DPSCs and evaluate the newly tissue 
formed histologically and immunologically. 
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5. CONCLUSIONS 
 
Based on the data and observations from the study, we can conclude that we were able to 
synthesize an auto-fluorescent PLLA-EY polymer by a ring opening polymerization process, 
using Eosin Y as a fluorescent initiator. The presence of fluorescent initiator in the polymer was 
confirmed by FT-IR where the peaks generated from Eosin Y were observed in the fluorescent 
polymer. UV-visible spectrometry also confirmed the presence of absorbance peak from Eosin Y 
in the PLLA-EY polymer at around 530nm.  
The microspheres were fabricated from the PLLA-EY polymer and were found to be 
auto-fluorescent under confocal microscopy. The florescence was in the emission range of EY, 
indicating the incorporation of EY in the polymer. 
Another finding was that as the M/I molar ratio was increased, an increase in the 
molecular weight of the polymer was observed. Also, the nanofibrous architecture changed with 
more well-defined nanofibers being formed with the higher molecular weight PLLA-EY 400:1 
polymer, as compared to the lower molecular weight PLLA-EY 200:1. 
Both short term (7d) and long term (21d) in vitro cytotoxicity results from the MTS 
assay confirmed that the fluorescent polymer was non-toxic to the DPSCs. It was interesting to 
see under light microscope, the formation of aggregates of NF microspheres that were held 
together by cellular extensions of DPSCs. The data also confirmed that the NF architecture was 
superior to the SW surface for cell growth, an observation that has been made in previous 
studies. The presence of EY did not appear to alter cellular response to the microparticles. 
Biodegradation of the NF microspheres was not seen until 6 weeks in vitro in PBS 
solution under the SEM, whereas no biodegradation was observed in SW microspheres even at 6 
weeks incubation.  
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Based on this data, the polymer should be useful for tissue engineering. Future studies 
are needed to determine the cell-microsphere interaction including cell adhesion, proliferation, 
differentiation, as well as and placement of the microspheres in vivo with the DPSCs to evaluate 
the de novo tissue formation. 
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